Yoshiyuki Aikawa insider trades: SBC Medical Group Holdings (SBC) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Yoshiyuki reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Apr 28, 2026 | SBC | ↓ Sell | 465,000 | $3.02 | $1.4M | Direct | Apr 29, 2026 (1d) |
| Mar 6, 2026 | SBC | ↓ Sell | 4,422,900 | $2.12 | $9.4M | By Aikawa Equity Management Co., Ltd. | Mar 10, 2026 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Yoshiyuki Aikawa's insider trades
Yoshiyuki Aikawa is Chairman and CEO at SBC Medical Group Holdings (SBC). Since Mar 6, 2026, Yoshiyuki has reported no open-market purchases and 2 sales worth $10.8M on SEC Form 4. In the last 12 months: 2 sales ($10.8M).
Their filings also include other transactions (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SBC insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.